Tandem Diabetes Care, Inc. TNDM
19.63 USD -0.44 (-2.19%)
As ofNov 16, 2026, 11:03 AM EST
19.63 Day range 20.11
12.26 52-week range 29.65
- YTD
- -10.69%
- 1 year
- +5.48%
News
seekingalpha.com Tandem: Wait Out The 2027 Transition Before Chasing The Turnaround I maintain a Hold rating on Tandem Diabetes Care: near-term underperformance offsets significant potential upside after 2027. TNDM's record Q3 revenue rose 13.8%, but international one-offs masked 9%…
benzinga.com Tandem Mobi Becomes Only Insulin Pump Offering Both Tubed and Tubeless Wear Options Global insulin delivery and diabetes technology company Tandem Diabetes Care, Inc. (NASDAQ:TNDM) secured U.S. Food and Drug Administration clearance for Tandem Mobi as the world's first and only…
benzinga.com Tandem Mobi Becomes Only Insulin Pump Offering Both Tubed and Tubeless Wear Options FDA clears Tandem Diabetes Care's Tandem Mobi as the first tubeless automated insulin delivery system with seven-day wear launching in 2027.
businesswire.com Tandem Mobi Now FDA Cleared as World's First and Only Tubeless AID System with up to Seven Days of Wear SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration…
businesswire.com Tandem Diabetes Care Receives Multiple Health Canada Approvals for t:slim X2 Insulin Pump SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced receipt of Health Canada approval…benzinga.com Barclays Maintains Equal-Weight on Tandem Diabetes Care, Raises Price Target to $20 Barclays analyst Christopher Pasquale maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Equal-Weight and raises the price target from $18 to $20.
benzinga.com Wells Fargo Maintains Overweight on Tandem Diabetes Care, Lowers Price Target to $25 Wells Fargo analyst Larry Biegelsen maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Overweight and lowers the price target from $27 to $25.
benzinga.com Tandem Diabetes Care Q3 2026 Earnings Call Transcript Tandem Diabetes Care (NASDAQ:TNDM) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…benzinga.com Tandem Diabetes Care Affirms FY2026 Sales Guidance of $1.065B-$1.085B vs $1.072B Est Tandem Diabetes Care (NASDAQ:TNDM) affirms FY2026 sales outlook from $1.065 billion-$1.085 billion to $1.065 billion-$1.085 billion vs $1.072 billion estimate.
benzinga.com Tandem Diabetes Care Q3 EPS $(0.10) Beats $(0.25) Estimate, Sales $283.690M Beat $265.922M Estimate Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.25) by 60 percent. This is a 67.74 percent increase over losses of…
